Lonza Group (LZAGY) Stock Forecast & Price Target

$59.34 +0.78 (+1.34%)

(As of 12/20/2024 05:55 PM ET)

Lonza Group - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Strong Buy

Based on 4 Analyst Ratings

Sell
0

Hold
0

Buy
4

Based on 4 Wall Street analysts who have issued ratings for Lonza Group in the last 12 months, the stock has a consensus rating of "Strong Buy." Out of the 4 analysts, 1 has given a buy rating, and 3 have given a strong buy rating for LZAGY.

Consensus Price Target

N/A

Get the Latest News and Ratings for LZAGY and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Lonza Group and its competitors.

LZAGY Analyst Ratings Over Time

Type	Current Forecast 12/22/23 to 12/21/24	1 Month Ago 11/22/23 to 11/21/24	3 Months Ago 9/23/23 to 9/22/24	1 Year Ago 12/22/22 to 12/22/23
Strong Buy	3 Strong Buy rating(s)	2 Strong Buy rating(s)	1 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	1 Buy rating(s)	1 Buy rating(s)	2 Buy rating(s)	3 Buy rating(s)
Hold	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)	1 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	N/A	N/A	N/A	N/A
Forecasted Upside	N/A	N/A	N/A	N/A
Consensus Rating	Strong Buy	Strong Buy	Buy	Moderate Buy

Most People Are Dead Wrong. (Ad)

Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines about artificial intelligence. Everyone's talking about AI right now. But see, I've been talking about it for years.

I call it my AI Retirement Playbook. I recommend you check it out now.

LZAGY Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

LZAGY Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Lonza Group Stock vs. The Competition

Type	Lonza Group	Medical Companies	S&P 500
Consensus Rating Score	3.75	2.81	2.51
Consensus Rating	Strong Buy	Moderate Buy	Moderate Buy
Predicted Upside	N/A	25,828.60% Upside	14.54% Upside
News Sentiment Rating	Positive News See Recent LZAGY News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating
11/27/2024	Redburn Atlantic 5 of 5 stars	J. Clark Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
10/9/2024	The Goldman Sachs Group 2 of 5 stars	J. Quigley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
6/23/2024	Berenberg Bank 2 of 5 stars	S. Bray Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
2/2/2024	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Hold ➝ Buy
10/9/2023	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Overweight
7/14/2023	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy
5/17/2023	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Hold
2/10/2023	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Kreger Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 01:55 PM ET.

Should I Buy Lonza Group Stock? LZAGY Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Friday, December 13, 2024. Please send any questions or comments about these Lonza Group pros and cons to contact@marketbeat.com.

Lonza Group
Bull Case

Here are some ways that investors could benefit from investing in Lonza Group AG:

Recent upgrades from analysts, including a "strong-buy" rating from Goldman Sachs and Redburn Atlantic, indicate positive market sentiment and potential for stock appreciation.
The current stock price of $59.24 reflects a significant increase from its 12-month low of $36.71, suggesting a recovery and potential for further growth.
Lonza Group AG operates in the pharmaceutical and biotech sectors, which are experiencing robust demand, particularly for innovative products and services, positioning the company for sustained revenue growth.
With a consensus earnings estimate of $1.65 per share for the current full year, the company shows potential for profitability, which is attractive for investors seeking income through dividends or capital gains.
The company has a diverse international presence, supplying products and services across multiple regions, which mitigates risks associated with market fluctuations in any single area.

Lonza Group
Bear Case

Investors should be bearish about investing in Lonza Group AG for these reasons:

William Blair recently reduced its FY2025 earnings estimates for Lonza Group AG, indicating potential challenges in meeting previous growth expectations.
The stock has shown volatility, with a 50-day moving average price of $61.42, which may concern investors looking for stability in their investments.
With a short percentage of float at 0%, there is little indication of bearish sentiment from short sellers, which could suggest a lack of confidence in the stock's future performance.
Institutional ownership is currently at 0%, which may indicate a lack of confidence from larger investors, potentially affecting the stock's stability and growth prospects.
The company has seen a month-to-month change in shares shorted, decreasing from 4,200 to 2,500, which could reflect a shift in investor sentiment that may not be favorable in the near term.

LZAGY Forecast - Frequently Asked Questions

: 4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Lonza Group in the last twelve months. There is currently 1 buy rating and 3 strong buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "strong buy" LZAGY shares.
: According to analysts, Lonza Group's stock has a predicted downside of -100.00% based on their 12-month stock forecasts.
: Over the previous 90 days, Lonza Group's stock had 2 upgrades by analysts.
: Lonza Group has been rated by research analysts at Redburn Atlantic, and The Goldman Sachs Group in the past 90 days.
: Analysts like Lonza Group more than other "medical" companies. The consensus rating for Lonza Group is Strong Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how LZAGY compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

Most People Are Dead Wrong. (Ad)

I call it my AI Retirement Playbook. I recommend you check it out now.

This page (OTCMKTS:LZAGY) was last updated on 12/21/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Lonza Group (LZAGY) Stock Forecast & Price Target